CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss	$ (77,141)	$ (169,590)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	370	704
Amortization of intangibles	72,965	85,511
Amortization of deferred financing costs	3,296	2,440
Accretion expense	5,279	4,057
PIK interest payable	233	0
Deferred income benefit	(238)	(200)
Loss on disposal of fixed assets	0	35
Stock compensation expense	2,491	2,718
Fair market value change in derivative liability	(47)	(8,935)
Fair market value change in contingent consideration	(1,045)	(11,652)
Gain from legal settlement	(10,476)	0
Gain from exchange of debt	(14,650)	0
Gain from sale of non-core assets	(2,000)	0
Impairment of fixed assets and intangibles	18,525	56,143
Decrease (increase) in operating assets (excluding effect of acquisitions):
Accounts receivable	5,412	11,009
Income taxes	1,291	5,321
Inventory	2,379	2,260
Prepaid expenses and other assets	3,830	(533)
Increase (decrease) in operating liabilities (excluding effect of acquisitions):
Accounts payable and accrued expenses	(2,115)	(7,960)
Accrued allowances	(4,652)	(1,717)
Arbitration award	(6,900)	17,522
Interest payable	(518)	(1,006)
Other liabilities	(2,228)	(2,628)
Net cash used in operating activities	(5,939)	(16,501)
Cash flows from investing activities:
Acquisitions	0	(583)
Proceeds from sale of non-core assets	2,000	0
Purchase of software and equipment	(18)	(984)
Net cash provided by (used in) investing activities	1,982	(1,567)
Cash flows from financing activities:
Payments on Treximet Secured Notes	(17,511)	(20,406)
Net proceeds from Delayed Draw Term Loan	30,000	0
Payments for financing costs	(13,587)	0
Payments on Exchangeable Notes	(500)	0
Net drawdowns (payments) on credit facilities	185	(1,000)
Payments on mortgages and capital leases	(52)	(77)
Proceeds from issuance of common stock, net of tax and costs	1,979	19,814
Shares withheld for the payment of taxes	(112)	(23)
Net cash provided by (used in) financing activities	402	(1,692)
Net decrease in cash and cash equivalents	(3,555)	(19,760)
Cash and cash equivalents, beginning of period	36,375	56,135
Cash and cash equivalents, end of period	$ 32,820	$ 36,375